C4 Therapeutics, Inc. (CCCC) — Revenue

Annual figures by fiscal year, from SEC filings.

2021: $45.78M2022: $31.10M2023: $20.76M2024: $35.58M2025: $35.95M$35.95M
2021Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$35.95M+1.0%
2024$35.58M+71.4%
2023$20.76M-33.3%
2022$31.10M-32.1%
2021$45.78M